Crescendo Biologics
Biopharmaceutical company developing Humabody® therapeutics in oncology with a focus on innovative targeted T-cell approaches.
73.3
73.3
NaN
NaN
NaN
NaN
Links
Valuation
$
Valuation
Funding
$
$ 32.00 M
$ 102.61 M
Funding
$ 32.00 M
$ 102.61 M
Statistics
NA
Ventures > Crescendo Biologics
Crescendo Biologics
Active
Action
Biopharmaceutical company developing Humabody® therapeutics in oncology with a focus on innovative targeted T-cell approaches.
- Funding
0and0